|Jan. 30, 2014|
A message from The Transplantation Society (TTS)
The joint-membership between TTS and ITNS was established late last year with a promising start. TTS hopes to welcome more ITNS members into the TTS fold in 2014. This year, TTS will be holding its biennial Congress in San Francisco in collaboration with AST and ASTS. The 2014 World Transplant Congress (WTC) will be held on July 26-31 in the Moscone West Convention Center. There will be a special symposia on Sunday, July 27 developed and co-sponsored by ITNS: "Helping Patients Achieve a High Quality of Life Post-transplant: Chronic Illness to Chronic Wellness."
ITNS members who join TTS get their abstract submission fee waived — that's a savings of $50 just for being part of TTS. ITNS-TTS members also receive a significant reduction in their registration fees. If you plan on attending WTC 2014, we urge you to become part of TTS beforehand so you can take advantage of these benefits and more. All TTS members enjoy free online access to the Transplantation journal as well as have access to a large library of scientific presentations online.
The WTC late breaking abstract submissions will start on March 3 and close on March 21, 2014. If you are an existing ITNS member and would like to add TTS membership, please call member services at 1-847-375-6340. TTS Membership for ITNS members costs only $50 for Full Members and $25 for Associates/ Trainees. A special rate is given to members from emerging countries.
We hope to see you in San Francisco at what promises to be an exciting Congress!More
Nursing Success TV Episode #4
This cold winter's hottest show is Nursing Success TV ... catch the latest episode in the ITNS Career Center!
The ITNS Career Center is proud to bring you Nursing Success TV, offering information and inspiration from nurses for nurses. Nursing Success TV is 100 percent focused on helping you meet the personal and professional challenges of nursing in today's world.
January's episode of Nursing Success TV includes:
Bioartificial kidney from novel polymer could reduce risk of transplants being rejected by human body
EU researchers are on the way to making parts of a bioartificial kidney out of a novel polymer — which could reduce the risk of transplants being rejected by the human body. More
What exactly is the job outlook for nurses?
By Keith Carlson
As 2014 begins, there is a great deal of discussion regarding the job prospects for nurses, especially those just entering the profession. With confusing opinions and projections about the reality of a nursing shortage in the United States, nursing students and recent graduates are understandably concerned. According to the Department of Labor Bureau of Labor Statistics, the growth in jobs for nurses is expected to increase 19 percent between 2012 and 2022, a rate of growth that apparently outpaces all other occupations. But several other factors must be taken into account as well.More
Revisiting multi-organ transplantation in the setting of scarcity
American Journal of Transplantation
In the setting of organ scarcity, the ethics of multi-organ transplantation deserve new examination. MOT offers substantial benefits to certain recipients, including avoiding serial surgeries. However, MOT candidates in the United States commonly receive priority for their nonprimary organ over many individuals who need that organ, which may undermine equity. More
Scotland encourages South Asians to donate organs
The Scottish government is encouraging members of the South Asian community in the country to sign up as organ donors after figures showed that fewer than one percent of people on the register are from this background. Only 1,512 people out of the more than two million Scots currently on the National Health Service organ donor register are from South Asian communities, the Scotland Herald reported.More
George Washington Bridge a lifeline for organ transplants at hospitals
New York Daily News
Traffic on the busy span — which was jammed for days after N.J. Gov. Chris Christie's staff ordered lanes closed as part of a political vendetta — could mean the difference between life and death in operations such as heart transplants. More
MIT Technology Review
Since 2008, eight patients have been given a new chance at life when surgeons replaced their badly damaged tracheas with man-made versions. This highly experimental technology is now moving from research labs to a manufacturing facility as a Boston-area company prepares to produce the scaffolds for growing the synthetic organs on a large scale. More
Drug shows promise for posttransplant new-onset diabetes
Renal & Urology News
In a small study, sitagliptin showed short-term efficacy and safety in the treatment of new-onset diabetes after renal transplantation. Dr. Thea Anine Strom Halden of Oslo University Hospital in Norway, and colleagues studied 19 long-term stable renal transplant recipients with new-onset diabetes after transplantation. The patients had a median age of 67 years. The investigators randomized patients to receive either sitagliptin 50-100 mg/day for four weeks followed by a sitagliptin-free period of four weeks or vice versa. Results showed that sitagliptin significantly increased first- and second-phase insulin secretion and lowered fasting and postprandial plasma glucose levels. The drug was well tolerated, and the researchers observed no effect on endothelial function and plasma markers of cardiovascular risk and no serious adverse events.More